Specialty Pharma Journal Specialty, Precision & Technology
By Kathleen P. Wolff, MBA Specialty Pharma Journal As the high cost of new biologic medicines sends U.S. healthcare costs soaring, payers are anxiously anticipating the introduction of biosimilar medicines – biological products, approved by FDA because they are highly similar to an already FDA-approved biological product. However, there is one …
Tag Archives: Specialty Pharma Education Center
September, 2015
March, 2015
-
16 March
Biosimilars 20/20: A Market Analysis of the Growth and Implications of Biosimilars Over the Next Five Years
TAMPA, FL, March 16, 2015 — The biosimilars event of the year – Biosimilars 20/20 – is scheduled for June 3-4, 2015 at The Hub in Philadelphia, PA. The event promises to provide an in-depth look into the future of the biosimilars market and address challenges of implementation. Biosimilars 20/20 …
-
9 March
The Specialty Pharma Education Center (SPEC) Offers Accredited Education Free of Charge
TAMPA, FL, March 9, 2015 — The Specialty Pharma Education Center (SPEC), a global leader in specialty pharmacy education, announced that it no longer requires users to be members of the National Association of Specialty Pharmacy (NASP) to access the education center. The move paves the way for greater participation …